Table 2.
Presence of missed cases screened by NBS or presence of metabolic crisis in undiagnosed newborns due to COVID-19 pandemic, per centre
Definitely | Probably | Probably not | Definitely not | |
Possible missed cases | ||||
Europe | 0 (0) | 4.5 (20.5) | 14.5 (65.9) | 3 (13.6) |
Oceania | 0 (0) | 0 (0) | 2 (100) | 0 (0) |
MENA | 0 (0) | 2 (50.0) | 1 (25.0) | 1 (25.0) |
Asia | 1 (12.5) | 5 (62.5) | 0 (0) | 2 (25.0) |
North and Central America | 0 (0) | 0 (0) | 3 (100) | 0 (0) |
World | 1 (2.6) | 11.5 (29.5) | 20.5 (52.7) | 6 (15.4) |
Possible cases of metabolic crisis in undiagnosed newborns | ||||
Europe | 0 (0) | 2 (8.7) | 8.5 (37.0) | 12.5 (54.3) |
Oceania | 0 (0) | 0 (0) | 0 (0) | 3 (100) |
MENA | 0 (0) | 2 (50.0) | 1 (25.0) | 1 (25.0) |
Asia | 1 (12.5) | 3 (37.5) | 3 (37.5) | 1 (12.5) |
North and Central America | 1 (33.3) | 0 (0) | 2 (66.7) | 0 (0) |
World | 2 (4.9) | 7 (17.1) | 14.5 (35.4) | 17.5 (40.7) |
Data are presented as absolute number (%).
MENA, Middle East and North Africa; NBS, newborn screening.